{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:23:32Z","timestamp":1772846612404,"version":"3.50.1"},"reference-count":54,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSAMC"],"published-print":{"date-parts":[[2019,3,18]]},"abstract":"<jats:sec>\n<jats:title>Background: <\/jats:title>\n<jats:p>\u03b1-Synuclein (\u03b1S) is the precursor protein present in Lewy Bodies that helps\nin the formation of highly ordered amyloid fibrils that is associated with the occurrence of Parkinson\u2019s\ndisease, a neuro-degenerative disorder. Many reports have now been focused on finding the\nprobable targets to weaken this debilitating disease. Recently \u03b3-synuclein (\u03b3S), a presynaptic protein,\nwas highlighted to inhibit the aggregation propensity of \u03b1S both in vivo and in vitro. However the nature,\nlocation and specificity of molecular interactions existing between the \u03b1S and \u03b3S is not known\nin spite of the potential importance of \u03b3S as an inhibitor of \u03b1S.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p> To understand the inhibition of \u03b1S aggregation by \u03b3S at the molecular level.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>  Umbrella sampling method was used along with molecular dynamics simulation to investigate\nthe conformational dynamics, degree of association and molecular interaction between the\nmonomeric units in the \u03b1S\/\u03b3S hetero-dimer.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results and Discussion: <\/jats:title>\n<jats:p>The dissociation energy barrier for \u03b1S\/\u03b3S hetero-dimer was found to be higher than \u03b1S\/\u03b1S homo-dimer. \u03b1S can therefore readily form a hetero-dimer by combining with \u03b3S than forming a homo-dimer. We also observed strong transient interactions involving hydrogen bonds, salt-bridges and non-bonded contacts between the monomeric units in \u03b1S\/\u03b3S hetero-dimer.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion: <\/jats:title>\n<jats:p>Our findings suggest that \u03b3S may inhibit the aggregation propensity of \u03b1S.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871524918666181012160439","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T02:31:13Z","timestamp":1539570673000},"page":"24-30","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Computational Study on the Role of \u03b3-Synuclein in Inhibiting the \u03b1-Synuclein Aggregation"],"prefix":"10.2174","volume":"19","author":[{"given":"Airy","family":"Sanjeev","sequence":"first","affiliation":[{"name":"Molecular Modelling and Simulation Laboratory, Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, Assam, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata S.K.","family":"Mattaparthi","sequence":"additional","affiliation":[{"name":"Molecular Modelling and Simulation Laboratory, Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, Assam, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1096\/fj.08-119784","volume":"23","author":"Bisaglia M.","year":"2009","unstructured":"Bisaglia M, Mammi S, Bubacco L.  Structural insights on physiological functions and pathological effects of \u03b1-synuclein.","journal-title":"FASEB J"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"e83752","DOI":"10.1371\/journal.pone.0083752","volume":"8","author":"Jain N.","year":"2013","unstructured":"Jain N, Bhasne K, Hemaswasthi M, Mukhopadhyay S.  Structural and dynamical insights into the membrane-bound \u03b1-Synuclein.","journal-title":"PLoS One"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/07391102.2003.10506918","volume":"21","author":"Uversky V.N.","year":"2003","unstructured":"Uversky VN.  A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders.","journal-title":"J Biomol Struct Dyn"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/07391102.2008.10507197","volume":"25","author":"Yoon J.","year":"2008","unstructured":"Yoon J, Park J, Jang S, Lee K, Shin S.  Conformational characteristics of unstructured peptides: Alpha-synuclein.","journal-title":"J Biomol Struct Dyn"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.molmed.2013.04.002","volume":"19","author":"Deleersnijder A.","year":"2013","unstructured":"Deleersnijder A, Gerard M, Debyser Z, Baekelandt V.  The remarkable conformational plasticity of \u03b1-synuclein: Blessing or curse?","journal-title":"Trends Mol Med"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1101\/gr.8.9.871","volume":"8","author":"Lavedan C.","year":"1998","unstructured":"Lavedan C.  The Synuclein family.","journal-title":"Genome Res"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"11970","DOI":"10.1074\/jbc.M109541200","volume":"277","author":"Uversky V.N.","year":"2002","unstructured":"Uversky VN, Li J, Souillac P, Millett IS, Doniach S, Jakes R, Goedert M, Fink AL.  Biophysical properties of the synucleins and their propensities to fibrillate: Inhibition of \u03b1-synuclein assembly by \u03b2- and gamma-synucleins.","journal-title":"J Biol Chem"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"7562","DOI":"10.1074\/jbc.M412887200","volume":"280","author":"Snyder H.","year":"2005","unstructured":"Snyder H, Mensah K, Hsu C, Hashimoto M, Surgucheva IG, Festoff B, Surguchov A, Masliah E, Matouschek A, Wolozin B.  \u03b2-synuclein reduces proteosomal inhibition by \u03b1-synuclein but not \u03b3-synuclein.","journal-title":"J Biol Chem"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0006-8993(01)02772-X","volume":"914","author":"Rockenstein E.","year":"2001","unstructured":"Rockenstein E, Hansen LA, Mallory M, Trojanowski JQ, Galasko D, Masliah E.  Altered expression of the synuclein family mRNA in Lewy body and Alzheimer\u2019s disease.","journal-title":"Brain Res"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","volume":"79","author":"Bendor J.T.","year":"2013","unstructured":"Bendor JT, Logan TP, Edwards RH.  The function of \u03b1-synuclein.","journal-title":"Neuron"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"9335","DOI":"10.1523\/JNEUROSCI.18-22-09335.1998","volume":"18","author":"Buchman V.L.","year":"1998","unstructured":"Buchman VL, Hunter HJ, Pinon LG, Thompson J, Privalova EM, Ninkina NN, Davies AM.  Persyn, a member of the synuclein family, influences neurofilament network integrity.","journal-title":"J Neurosci"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"e39465","DOI":"10.1371\/journal.pone.0039465","volume":"7","author":"Angot E.","year":"2012","unstructured":"Angot E, Steiner JA.  LemaTome, C.M.; Ekstrom, P.; Mattsson, B.; Bjorklund, A.; Brundin, P. \u03b1-Synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons","journal-title":"PLoS One"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/path.2465","volume":"217","author":"Hua H.","year":"2009","unstructured":"Hua H, Xu L, Wang J, Jing J, Luo T, Jiang Y.  Up-regulation of gamma-synuclein contributes to cancer cell survival under endoplasmic reticulum stress.","journal-title":"J Pathol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10549-005-6938-0","volume":"94","author":"Inaba S.","year":"2005","unstructured":"Inaba S, Li C, Shi YE, Song DQ, Jiang JD, Liu J.  Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells.","journal-title":"Breast Cancer Res Treat"},{"key":"ref=15","first-page":"759","volume":"57","author":"Ji H.","year":"1997","unstructured":"Ji H, Liu YE, Jia T, Wang M, Liu J, Xiao G, Joseph BK, Rosen C, Shi YE.  Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing.","journal-title":"Cancer Res"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"35050","DOI":"10.1074\/jbc.M201650200","volume":"277","author":"Pan Z.Z.","year":"2002","unstructured":"Pan ZZ, Bruening W, Giasson BI, Lee VM, Godwin AK.  Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways.","journal-title":"J Biol Chem"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2154::AID-CNCR23>3.0.CO;2-9","volume":"88","author":"Bruening W.","year":"2000","unstructured":"Bruening W, Giasson BI, Klein-Szanto AJ, Lee VM, Trojanowski JQ, Godwin AK.  Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary.","journal-title":"Cancer"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1158\/0008-5472.CAN-03-3650","volume":"64","author":"Jiang Y.","year":"2004","unstructured":"Jiang Y, Liu YE, Goldberg ID, Shi YE.  \u03b3 Synuclein, a novel heat-shock protein-associated chaperone, stimulates ligand-dependent estrogen receptor \u03b1 signaling and mammary tumorigenesis.","journal-title":"Cancer Res"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0003-9861(02)00664-1","volume":"410","author":"Surgucheva I.G.","year":"2003","unstructured":"Surgucheva IG, Sivak JM, Fini ME, Palazzo RE, Surguchov AP.  \u03b3 Synuclein, a novel heat-shock protein-associated chaperone, stimulates ligand-dependent estrogen receptor \u03b1 signaling and mammary tumorigenesis.","journal-title":"Arch Biochem Biophys"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"13450","DOI":"10.1073\/pnas.96.23.13450","volume":"96","author":"Galvin J.E.","year":"1999","unstructured":"Galvin JE, Uryu K, Lee VM, Trojanowski JQ.  Axon pathology in Parkinson\u2019s disease and Lewy body dementia hippocampus contains \u03b1-, \u03b2-, and gamma-synuclein.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/hmg\/ddp090","volume":"18","author":"Ninkina N.","year":"2009","unstructured":"Ninkina N, Peters O, Millership S, Salem H, van der Putten H, Buchman VL.  Gamma synucleinopathy: Neurodegeneration associated with overexpression of the mouse protein.","journal-title":"Hum Mol Genet"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/archneurol.2010.177","volume":"67","author":"Nishioka K.","year":"2010","unstructured":"Nishioka K, Wider C, Vilarino-Guell C, Soto-Ortolaza AI, Lincoln SJ, Kachergus JM, Jasinska-Myga B, Ross OA, Rajput A, Robinson CA, Ferman TJ, Wszolek ZK, Dickson DW, Farrer MJ.  Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease.","journal-title":"Arch Neurol"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0166-2236(97)01213-7","volume":"21","author":"Clayton D.F.","year":"1998","unstructured":"Clayton DF, George JM.  The Synucleins: A family of proteins involved in synaptic function, plasticity, neurodegeneration and disease.","journal-title":"Trends Neurosci"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","volume":"9","author":"Ueda K.","year":"1993","unstructured":"Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y, Saitoh T.  Molecular cloning of cDNA encoding anon-recognized component of amyloid in Alzheimer disease.","journal-title":"Proc Natl Acad Sci"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1080\/07391102.2014.951689","volume":"33","author":"Berhanu W.M.","year":"2014","unstructured":"Berhanu WM, Masunov AE.  Atomistic mechanism of polyphenol amyloid aggregation inhibitors: Molecular dynamics study of Curcumin, Exifone, and Myricetin interaction with the segment of tau peptide oligomer.","journal-title":"J Biomol Struct Dyn"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"32036","DOI":"10.1074\/jbc.M111.242958","volume":"286","author":"Lamberto C.R.","year":"2011","unstructured":"Lamberto CR, Torres-Monserrat V, Bertoncini CW, Salvatella X, Zweckstetter M, Griesinger C, Fernandez CO.  Toward the discovery of effective polycyclic inhibitors of \u03b1-synuclein amyloid assembly.","journal-title":"J Biol Chem"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"8322","DOI":"10.1021\/bi901285x","volume":"48","author":"Lendel C.","year":"2009","unstructured":"Lendel C, Bertoncini CW, Cremades N, Waudby CA, Vendruscolo M, Dobson CM, Schenk D, Christodoulou J, Toth G.  On the mechanism of nonspecific inhibitors of protein aggregation: Dissecting the interactions of alpha-synuclein with congo red and lacmoid.","journal-title":"Biochemistry"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"8206","DOI":"10.1021\/bi900506b","volume":"48","author":"Meng X.Y.","year":"2009","unstructured":"Meng XY, Munishkina LA, Fink AL, Uversky VN.  molecular mechanisms underlying the flavonoid-induced inhibition of \u03b1-synuclein fibrillation.","journal-title":"Biochemistry"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1021\/bi8002378","volume":"47","author":"Rao J.N.","year":"2008","unstructured":"Rao JN, Dua V, Ulmer TS.  Characterization of \u03b1-synuclein interactions with selected aggregation-inhibiting small molecules.","journal-title":"Biochemistry"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0014-5793(01)03115-5","volume":"509","author":"Tofaris G.K.","year":"2001","unstructured":"Tofaris GK, Layfield R, Spillantini MG.  Alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome.","journal-title":"FEBS Lett"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","volume":"297","author":"McNaught K.S.","year":"2001","unstructured":"McNaught KS, Jenner P.  Proteasomal function is impaired in substantia nigra in Parkinson\u2019s disease.","journal-title":"Neurosci Lett"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1093\/hmg\/ddl242","volume":"15","author":"Fan Y.","year":"2006","unstructured":"Fan Y, Limprasert P, Murray IV, Smith AC, Lee VMY, Trojanowski JQ, Sopher BL, Spada ARL.  \u03b2-synuclein modulates \u03b1-synuclein neurotoxicity by reducing \u03b1-synuclein protein expression.","journal-title":"Hum Mol Genet"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"23622","DOI":"10.1074\/jbc.M313784200","volume":"279","author":"Hashimoto M.","year":"2004","unstructured":"Hashimoto M, Bar-On P, Ho G, Takenouchi T, Rockenstein E, Crews L, Masliah E.  \u03b2-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson\u2019s disease.","journal-title":"J Biol Chem"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.gt.3302349","volume":"11","author":"Hashimoto M.","year":"2004","unstructured":"Hashimoto M, Rockenstein E, Mante M, Crews L, Bar-On P, Gage FH, Marr R, Masliah E.  An anti-aggregation gene therapy strategy for Lewy body disease utilizing \u03b2-synuclein  in a transgenic model.","journal-title":"Gene Ther"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0896-6273(01)00462-7","volume":"32","author":"Hashimoto M.","year":"2001","unstructured":"Hashimoto M, Rockenstein E, Mante M, Mallory M, Masliah E.  \u03b2-Synuclein inhibits \u03b1-synuclein aggregation: A possible role as an anti-parkinsonian factor.","journal-title":"Neuron"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/bi020604a","volume":"42","author":"Park J.Y.","year":"2003","unstructured":"Park JY, Lansbury Jr.  \u03b2-synuclein inhibits formation of \u03b1-synuclein protofibrils: A possible therapeutic strategy against Parkinson\u2019s disease.","journal-title":"Biochemistry"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/j.1742-4658.2007.05733.x","volume":"274","author":"Tsigelny I.F.","year":"2007","unstructured":"Tsigelny IF, Bar-On P, Sharikov Y, Crews L, Hashimoto M, Miller MA, Keller SH, Platoshyn O, Yuan JXY, Mashiah E.  Dynamics of \u03b1-synuclein aggregation and inhibition of pore-like oligomer development by \u03b2-synuclein.","journal-title":"FEBS J"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0168-9525(00)02024-2","volume":"16","author":"Rice P.","year":"2000","unstructured":"Rice P, Longden I, Bleasby A.  EMBOSS: The european molecular biology open software suite.","journal-title":"Trends Genet"},{"key":"ref=39","first-page":"488","volume":"4","author":"Mehta K.","year":"2013","unstructured":"Mehta K, Poddar R, Mukhopadhyay K, Kumar M.  Insight into interaction of \u03b3-synuclein inhibiting \u03b1-synuclein oligomers-a possible strategy to cure parkinson\u2019s disease.","journal-title":"Intl J Adv Biotechnol Res"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1063\/1.1749657","volume":"3","author":"Kirkwood J.G.","year":"1935","unstructured":"Kirkwood JG.  Statistical mechanics of fluid mixtures.","journal-title":"J Chem Phys"},{"key":"ref=41","first-page":"185","author":"Duhovny D.","year":"2002","unstructured":"Duhovny D, Nussinov R, Wolfson HJ.","journal-title":"Efficient unbound docking of rigid molecules"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/prot.21495","volume":"69","author":"Andrusier N.","year":"2007","unstructured":"Andrusier N, Nussinov R, Wolfson HJ.  FireDock: Fast interaction refinement in molecular docking.","journal-title":"Proteins"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/nar\/29.1.221","volume":"29","author":"Laskowski R.A.","year":"2001","unstructured":"Laskowski RA.  PDBsum: Summaries and analyses of PDB structures.","journal-title":"Nucleic Acids Res"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2105-9-40","volume":"9","author":"Zhang Y.","year":"2008","unstructured":"Zhang Y.  I-TASSER server for protein 3D structure prediction.","journal-title":"BMC Bioinformatics"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"Berman H.M.","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE.  The protein data bank.","journal-title":"Nucleic Acids Res"},{"key":"ref=46","unstructured":""},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/prot.21123","volume":"65","author":"Hornak V.","year":"2006","unstructured":"Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simmerling C.  Comparison of multiple Amber force fields and development of improved protein backbone parameters.","journal-title":"Proteins"},{"key":"ref=48","first-page":"1","volume":"7","author":"Sanjeev A.","year":"2017","unstructured":"Sanjeev A, Mattaparthi VSK.  Effect of C-terminal truncations on the aggregation propensity of \u03b1lpha-synuclein - a potential of mean force study.","journal-title":"J Mol Imaging Dyn"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1006\/jmbi.1996.0859","volume":"267","author":"Zhang C.","year":"1997","unstructured":"Zhang C, Vasmatzis G, Cornette JL, DeLisi C.  Determination of atomic desolvation energies from the structures of crystallized proteins.","journal-title":"J Mol Biol"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/jcc.540161104","volume":"16","author":"Grossfield A.","year":"1995","unstructured":"Grossfield A.  Multidimensional free-energy calculations using the weighted histogram analysis method.","journal-title":"J Comput Chem"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/jcc.540130812","volume":"13","author":"Kumar S.","year":"1992","unstructured":"Kumar S, Bouzida D, Swendsen RH, Kollmanand PA, Rosenberg JM.  The weighted histogram analysis method for free-energy calculations on biomolecules. I. the method.","journal-title":"J Comput Chem"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0010-4655(00)00215-0","volume":"135","author":"Souaille M.","year":"2001","unstructured":"Souaille M, Roux B.  Extension to the weighted histogram analysis method: Combining umbrella sampling with free energy calculations.","journal-title":"Comput Phys Commun"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/0009-2614(74)80109-0","volume":"28","author":"Torrie G.M.","year":"1974","unstructured":"Torrie GM, Valleau JP.  Modeling condensed phase reaction dynamics.","journal-title":"Chem Phys Lett"},{"key":"ref=54","first-page":"1","author":"Sanjeev A.","year":"2016","unstructured":"Sanjeev A, Sahu RK, Mattaparthi VSK.  Potential of mean force and molecular dynamics study on the transient interactions between \u03b1 and \u03b2 synuclein that drive inhibition of \u03b1-synuclein aggregation.","journal-title":"J Biomol Struct Dyn"}],"container-title":["Central Nervous System Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/166215","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T11:26:13Z","timestamp":1572089173000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/166215\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3,18]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871524918666181012160439","relation":{},"ISSN":["1871-5249"],"issn-type":[{"value":"1871-5249","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3,18]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-07-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}